Hydrogenated (arachidic acid) phosphatidylcholine (CAS 61596-53-0)
Hydrogenated (arachidic acid) phosphatidylcholine (CAS 61596-53-0) is a fully saturated phospholipid derivative with enhanced stability. Used in pharmaceutical liposomes, cosmetic emulsifiers, and food-grade stabilizers, it features a saturated C20 fatty acid chain for superior barrier repair and long-term product efficacy.
氢化花生酸磷脂酰胆碱（CAS 61596-53-0）是一种完全氢化的磷脂衍生物，具有优异的热稳定性和抗氧化性。适用于药物脂质体、化妆品乳化剂及食品级稳定剂，其饱和C20脂肪酸链可强化屏障修复并延长产品保质期。
1. Chemical Composition
| Molecular formula: C₄₈H₉₆NO₈P |
| 物理状态: 白色/类白色粉末，熔点高（约500°C）。 |
| Solubility: Poor water solubility but dissolves in organic solvents like chloroform or ethanol. |
| 分子式: C₄₈H₉₆NO₈P |
| 物理状态: 白色/类白色粉末，熔点高（约500°C）。 |
| 溶解性: 难溶于水，可溶于氯仿或乙醇等有机溶剂。 |
2. Applications
| Pharmaceuticals: Acts as a liposome matrix for controlled drug release (e.g., oncology, antifungal agents). |
| 医药: 作为脂质体基质，用于药物控释（如抗肿瘤、抗真菌药物）。 |
| Cosmetics: Enhances skin barrier function, reduces transepidermal water loss, and improves hydration in anti-aging and sensitive-skin formulations. |
| 化妆品: 增强皮肤屏障功能，减少经表皮水分流失，改善抗衰老及敏感肌配方的水润度。 |
| Food Industry: Stabilizes emulsions in dairy, baked goods, and confectionery. |
| 食品工业: 稳定乳制品、烘焙食品及糖果中的乳液。 |
3. Functional Advantages
| Stability: Resists oxidation and hydrolysis, extending shelf life. |
| 稳定性: 抗氧化、耐水解，延长保质期。 |
| Barrier Repair: Forms a lipid bilayer mimicking the skin’s natural structure to protect against environmental stressors. |
| 屏障修复: 形成仿生脂质双层结构，抵御环境刺激。 |
4. Production
| Derived from soybean or egg phospholipids via catalytic hydrogenation of arachidic acid chains. |
| 生产工艺: 源自大豆或蛋黄磷脂，通过花生酸链的催化氢化制备。 |
| Commercial purity: ≥95% (phospholipid content). |
| 商业纯度: ≥95%（磷脂含量）。 |
5. Market Trends
| Rising demand in clean beauty and nutraceutical sectors due to eco-friendly sourcing and safety profiles. |
| 市场趋势: 因环保原料与安全性，清洁美妆和营养保健品需求增长。 |
| Preferred over non-hydrogenated variants for stability in high-performance formulations. |
| 相较于未氢化变体，其稳定性更适配高性能配方。 |
Technical Notes
| CAS 61596-53-0 distinguishes it from docosanoic acid (C22) variants, with a shorter C20 fatty acid chain. |
| 技术说明: CAS 61596-53-0与二十二烷酸（C22）变体区分，含更短的C20脂肪酸链。 |
| Safety data sheets (SDS) are critical for bulk procurement, as toxicological profiles vary by application. |
| 安全数据表（SDS）对大批量采购至关重要，因其毒理特性因应用场景而异。 |
sale@pharma-peptides.com
请到「后台-用户-个人资料」中填写个人说明。